P-313 Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide

Gespeichert in:

Autor*in:	Germing, U. [verfasserIn] Giagounidis, A. Büsche, G. Platzbecker, U. Götze, K. Nolte, F. Schlenk, R.F. Letsch, A. Ganser, A. Lübbert, M. Bug, G. Schafhausen, P. Schemenau, J. Haase, D.

Format:	E-Artikel

Erschienen:	2013

Übergeordnetes Werk:	Enthalten in: N - Li, Danyang ELSEVIER, 2019, clinical and laboratory studies, Amsterdam [u.a.]
Übergeordnetes Werk:	volume:37 ; year:2013 ; pages:163

Links:	Volltext

DOI / URN:	10.1016/S0145-2126(13)70360-6

Katalog-ID:	ELV016621654

Internformat


LEADER	01000caa a22002652 4500
001	ELV016621654
003	DE-627
005	20230623131058.0
007	cr uuu---uuuuu
008	180602s2013 xx \|\|\|\|\|o 00\| \|\|und c
024	7		\|a 10.1016/S0145-2126(13)70360-6 \|2 doi
028	5	2	\|a GBVA2013003000024.pica
035			\|a (DE-627)ELV016621654
035			\|a (ELSEVIER)S0145-2126(13)70360-6
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
082	0		\|a 610
082	0	4	\|a 610 \|q DE-600
082	0	4	\|a 333.7 \|a 610 \|q VZ
084			\|a 43.12 \|2 bkl
084			\|a 43.13 \|2 bkl
084			\|a 44.13 \|2 bkl
100	1		\|a Germing, U. \|e verfasserin \|4 aut
245	1	0	\|a P-313 Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide
264		1	\|c 2013
336			\|a nicht spezifiziert \|b zzz \|2 rdacontent
337			\|a nicht spezifiziert \|b z \|2 rdamedia
338			\|a nicht spezifiziert \|b zu \|2 rdacarrier
700	1		\|a Giagounidis, A. \|4 oth
700	1		\|a Büsche, G. \|4 oth
700	1		\|a Platzbecker, U. \|4 oth
700	1		\|a Götze, K. \|4 oth
700	1		\|a Nolte, F. \|4 oth
700	1		\|a Schlenk, R.F. \|4 oth
700	1		\|a Letsch, A. \|4 oth
700	1		\|a Ganser, A. \|4 oth
700	1		\|a Lübbert, M. \|4 oth
700	1		\|a Bug, G. \|4 oth
700	1		\|a Schafhausen, P. \|4 oth
700	1		\|a Schemenau, J. \|4 oth
700	1		\|a Haase, D. \|4 oth
773	0	8	\|i Enthalten in \|n Elsevier Science \|a Li, Danyang ELSEVIER \|t N \|d 2019 \|d clinical and laboratory studies \|g Amsterdam [u.a.] \|w (DE-627)ELV002185202
773	1	8	\|g volume:37 \|g year:2013 \|g pages:163
856	4	0	\|u https://doi.org/10.1016/S0145-2126(13)70360-6 \|3 Volltext
912			\|a GBV_USEFLAG_U
912			\|a GBV_ELV
912			\|a SYSFLAG_U
912			\|a SSG-OLC-PHA
912			\|a SSG-OPC-GGO
936	b	k	\|a 43.12 \|j Umweltchemie \|q VZ
936	b	k	\|a 43.13 \|j Umwelttoxikologie \|q VZ
936	b	k	\|a 44.13 \|j Medizinische Ökologie \|q VZ
951			\|a AR
952			\|d 37 \|j 2013 \|h 163 \|y 37.2013, S163-
953			\|2 045F \|a 610

Indexfelder

author_variant	u g ug
matchkey_str	germingugiagounidisabschegplatzbeckerugt:2013----:33epnenporsinaefainsihrmrmsnioaedlqpsoit
hierarchy_sort_str	2013
bklnumber	43.12 43.13 44.13
publishDate	2013
allfields	10.1016/S0145-2126(13)70360-6 doi GBVA2013003000024.pica (DE-627)ELV016621654 (ELSEVIER)S0145-2126(13)70360-6 DE-627 ger DE-627 rakwb 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Germing, U. verfasserin aut P-313 Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide 2013 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Giagounidis, A. oth Büsche, G. oth Platzbecker, U. oth Götze, K. oth Nolte, F. oth Schlenk, R.F. oth Letsch, A. oth Ganser, A. oth Lübbert, M. oth Bug, G. oth Schafhausen, P. oth Schemenau, J. oth Haase, D. oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:37 year:2013 pages:163 https://doi.org/10.1016/S0145-2126(13)70360-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 37 2013 163 37.2013, S163- 045F 610
spelling	10.1016/S0145-2126(13)70360-6 doi GBVA2013003000024.pica (DE-627)ELV016621654 (ELSEVIER)S0145-2126(13)70360-6 DE-627 ger DE-627 rakwb 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Germing, U. verfasserin aut P-313 Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide 2013 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Giagounidis, A. oth Büsche, G. oth Platzbecker, U. oth Götze, K. oth Nolte, F. oth Schlenk, R.F. oth Letsch, A. oth Ganser, A. oth Lübbert, M. oth Bug, G. oth Schafhausen, P. oth Schemenau, J. oth Haase, D. oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:37 year:2013 pages:163 https://doi.org/10.1016/S0145-2126(13)70360-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 37 2013 163 37.2013, S163- 045F 610
allfields_unstemmed	10.1016/S0145-2126(13)70360-6 doi GBVA2013003000024.pica (DE-627)ELV016621654 (ELSEVIER)S0145-2126(13)70360-6 DE-627 ger DE-627 rakwb 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Germing, U. verfasserin aut P-313 Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide 2013 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Giagounidis, A. oth Büsche, G. oth Platzbecker, U. oth Götze, K. oth Nolte, F. oth Schlenk, R.F. oth Letsch, A. oth Ganser, A. oth Lübbert, M. oth Bug, G. oth Schafhausen, P. oth Schemenau, J. oth Haase, D. oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:37 year:2013 pages:163 https://doi.org/10.1016/S0145-2126(13)70360-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 37 2013 163 37.2013, S163- 045F 610
allfieldsGer	10.1016/S0145-2126(13)70360-6 doi GBVA2013003000024.pica (DE-627)ELV016621654 (ELSEVIER)S0145-2126(13)70360-6 DE-627 ger DE-627 rakwb 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Germing, U. verfasserin aut P-313 Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide 2013 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Giagounidis, A. oth Büsche, G. oth Platzbecker, U. oth Götze, K. oth Nolte, F. oth Schlenk, R.F. oth Letsch, A. oth Ganser, A. oth Lübbert, M. oth Bug, G. oth Schafhausen, P. oth Schemenau, J. oth Haase, D. oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:37 year:2013 pages:163 https://doi.org/10.1016/S0145-2126(13)70360-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 37 2013 163 37.2013, S163- 045F 610
allfieldsSound	10.1016/S0145-2126(13)70360-6 doi GBVA2013003000024.pica (DE-627)ELV016621654 (ELSEVIER)S0145-2126(13)70360-6 DE-627 ger DE-627 rakwb 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Germing, U. verfasserin aut P-313 Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide 2013 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Giagounidis, A. oth Büsche, G. oth Platzbecker, U. oth Götze, K. oth Nolte, F. oth Schlenk, R.F. oth Letsch, A. oth Ganser, A. oth Lübbert, M. oth Bug, G. oth Schafhausen, P. oth Schemenau, J. oth Haase, D. oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:37 year:2013 pages:163 https://doi.org/10.1016/S0145-2126(13)70360-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 37 2013 163 37.2013, S163- 045F 610
source	Enthalten in N Amsterdam [u.a.] volume:37 year:2013 pages:163
sourceStr	Enthalten in N Amsterdam [u.a.] volume:37 year:2013 pages:163
format_phy_str_mv	Article
bklname	Umweltchemie Umwelttoxikologie Medizinische Ökologie
institution	findex.gbv.de
dewey-raw	610
isfreeaccess_bool	false
container_title	N
authorswithroles_txt_mv	Germing, U. @@aut@@ Giagounidis, A. @@oth@@ Büsche, G. @@oth@@ Platzbecker, U. @@oth@@ Götze, K. @@oth@@ Nolte, F. @@oth@@ Schlenk, R.F. @@oth@@ Letsch, A. @@oth@@ Ganser, A. @@oth@@ Lübbert, M. @@oth@@ Bug, G. @@oth@@ Schafhausen, P. @@oth@@ Schemenau, J. @@oth@@ Haase, D. @@oth@@
publishDateDaySort_date	2013-01-01T00:00:00Z
hierarchy_top_id	ELV002185202
dewey-sort	3610
id	ELV016621654
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV016621654</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623131058.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2013 xx \|\|\|\|\|o 00\| \|\|und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0145-2126(13)70360-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013003000024.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV016621654</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0145-2126(13)70360-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">333.7</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Germing, U.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">P-313 Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Giagounidis, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Büsche, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Platzbecker, U.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Götze, K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nolte, F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schlenk, R.F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Letsch, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ganser, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lübbert, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bug, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schafhausen, P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schemenau, J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Haase, D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Li, Danyang ELSEVIER</subfield><subfield code="t">N</subfield><subfield code="d">2019</subfield><subfield code="d">clinical and laboratory studies</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002185202</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:37</subfield><subfield code="g">year:2013</subfield><subfield code="g">pages:163</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0145-2126(13)70360-6</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.12</subfield><subfield code="j">Umweltchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.13</subfield><subfield code="j">Umwelttoxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">37</subfield><subfield code="j">2013</subfield><subfield code="h">163</subfield><subfield code="y">37.2013, S163-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
author	Germing, U.
spellingShingle	Germing, U. ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 P-313 Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide
authorStr	Germing, U.
ppnlink_with_tag_str_mv	@@773@@(DE-627)ELV002185202
format	electronic Article
dewey-ones	610 - Medicine & health 333 - Economics of land & energy
delete_txt_mv	keep
author_role	aut
collection	elsevier
remote_str	true
illustrated	Not Illustrated
topic_title	610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl P-313 Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide
topic	ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13
topic_unstemmed	ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13
topic_browse	ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	zu
author2_variant	a g ag g b gb u p up k g kg f n fn r s rs a l al a g ag m l ml g b gb p s ps j s js d h dh
hierarchy_parent_title	N
hierarchy_parent_id	ELV002185202
dewey-tens	610 - Medicine & health 330 - Economics
hierarchy_top_title	N
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)ELV002185202
title	P-313 Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide
ctrlnum	(DE-627)ELV016621654 (ELSEVIER)S0145-2126(13)70360-6
title_full	P-313 Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide
author_sort	Germing, U.
journal	N
journalStr	N
isOA_bool	false
dewey-hundreds	600 - Technology 300 - Social sciences
recordtype	marc
publishDateSort	2013
contenttype_str_mv	zzz
container_start_page	163
author_browse	Germing, U.
container_volume	37
class	610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl
format_se	Elektronische Aufsätze
author-letter	Germing, U.
doi_str_mv	10.1016/S0145-2126(13)70360-6
dewey-full	610 333.7
title_sort	p-313 response and progression rate of patients with primary mds and isolated del(5q), ipss low/int1 under treatment with lenalidomide
title_auth	P-313 Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide
collection_details	GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO
title_short	P-313 Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide
url	https://doi.org/10.1016/S0145-2126(13)70360-6
remote_bool	true
author2	Giagounidis, A. Büsche, G. Platzbecker, U. Götze, K. Nolte, F. Schlenk, R.F. Letsch, A. Ganser, A. Lübbert, M. Bug, G. Schafhausen, P. Schemenau, J. Haase, D.
author2Str	Giagounidis, A. Büsche, G. Platzbecker, U. Götze, K. Nolte, F. Schlenk, R.F. Letsch, A. Ganser, A. Lübbert, M. Bug, G. Schafhausen, P. Schemenau, J. Haase, D.
ppnlink	ELV002185202
mediatype_str_mv	z
isOA_txt	false
hochschulschrift_bool	false
author2_role	oth oth oth oth oth oth oth oth oth oth oth oth oth
doi_str	10.1016/S0145-2126(13)70360-6
up_date	2024-07-06T20:01:03.694Z
_version_	1803861165285048320
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV016621654</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623131058.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2013 xx \|\|\|\|\|o 00\| \|\|und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0145-2126(13)70360-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013003000024.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV016621654</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0145-2126(13)70360-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">333.7</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Germing, U.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">P-313 Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Giagounidis, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Büsche, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Platzbecker, U.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Götze, K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nolte, F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schlenk, R.F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Letsch, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ganser, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lübbert, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bug, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schafhausen, P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schemenau, J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Haase, D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Li, Danyang ELSEVIER</subfield><subfield code="t">N</subfield><subfield code="d">2019</subfield><subfield code="d">clinical and laboratory studies</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002185202</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:37</subfield><subfield code="g">year:2013</subfield><subfield code="g">pages:163</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0145-2126(13)70360-6</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.12</subfield><subfield code="j">Umweltchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.13</subfield><subfield code="j">Umwelttoxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">37</subfield><subfield code="j">2013</subfield><subfield code="h">163</subfield><subfield code="y">37.2013, S163-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
score	7.4003696

Nicht das Richtige dabei?

Schreiben Sie uns!

P-313 Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?